wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36407018-5AB41A30-7B1C-4545-9C02-27BF408B6277
Q36407018-5AB41A30-7B1C-4545-9C02-27BF408B6277
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407018-5AB41A30-7B1C-4545-9C02-27BF408B6277
A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.
P2860
Q36407018-5AB41A30-7B1C-4545-9C02-27BF408B6277
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36407018-5AB41A30-7B1C-4545-9C02-27BF408B6277
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c8d588609c5c9dcc307a7992a0f9bd02b06774e8
P2860
A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.